Roche acquired Verum Diagnostica for €11M cash plus up to €2M in milestones (~$17M total), expanding its coagulation diagnostics portfolio. Below $250M threshold but a clean diagnostics-platform tuck-in.
Did it work? Outcome assessment
Strategic verdict
Achieved Stated Rationale
Financial impact
Neutral
Pipeline outcome
Assets Advanced
Assessment window: 5yr post-close.
Key facts
AnnouncedDec 05, 2011
ClosedJan 31, 2012
Deal value$17M
Deal typeAcquisition/Merger
Therapeutic areaCoagulation/platelet function diagnostics
IndicationsCoagulation/platelet function diagnostics
Key assetsMultiplate platelet function analyzer
MechanismImpedance aggregometry platelet function testing